Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for myeloma patients: early trial tests promising drug

NCT ID NCT05650632

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new drug called etentamig (ABBV-383) for adults with multiple myeloma that has returned or stopped responding to other treatments. The main goal is to find the safest and most effective dose and to closely monitor for side effects, including a serious immune reaction called cytokine release syndrome (CRS). About 210 participants worldwide will receive the drug by IV infusion for up to three years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AP-HP - Hopital Saint-Antoine /ID# 252326

    COMPLETED

    Paris, 75012, France

  • Atrium Health Wake Forest Baptist Medical Center /ID# 251165

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

  • CHU Poitiers - La miletrie /ID# 251219

    RECRUITING

    Poitiers, Vienne, 86000, France

  • Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 251196

    RECRUITING

    Nantes, Pays de la Loire Region, 44000, France

  • Fort Wayne Medical Oncology And Hematology /ID# 268179

    RECRUITING

    Fort Wayne, Indiana, 46804, United States

  • Fred Hutchinson Cancer Center. /ID# 267940

    RECRUITING

    Seattle, Washington, 98109-4405, United States

  • HCL - Hopital Lyon Sud /ID# 251223

    RECRUITING

    Pierre-Bénite, Rhone, 69495, France

  • Hadassah Medical Center-Hebrew University /ID# 252079

    RECRUITING

    Jerusalem, Jerusalem, 91120, Israel

  • Highlands Oncology Group - Springdale /ID# 267742

    RECRUITING

    Springdale, Arkansas, 72762, United States

  • Hope And Healing Cancer Services /ID# 268536

    RECRUITING

    Hinsdale, Illinois, 60521, United States

  • Hopitaux Universitaires Henri Mondor - Hopital Henri Mondor /ID# 252101

    COMPLETED

    Créteil, Paris, 94010, France

  • Hospital Universitario Marques de Valdecilla /ID# 251528

    RECRUITING

    Santander, Cantabria, 39008, Spain

  • Hospital Universitario Puerta de Hierro - Majadahonda /ID# 251545

    COMPLETED

    Majadahonda, Madrid, 28222, Spain

  • Hospital Universitario de Salamanca /ID# 251529

    RECRUITING

    Salamanca, 37711, Spain

  • Institut Paoli-Calmettes /ID# 252100

    COMPLETED

    Marseille, Bouches-du-Rhone, 13009, France

  • Juravinski Cancer Centre /ID# 252053

    RECRUITING

    Hamilton, Ontario, L8V 1C3, Canada

  • Mayo Clinic - Rochester /ID# 251164

    RECRUITING

    Rochester, Minnesota, 55905-0001, United States

  • Mayo Clinic Arizona /ID# 251405

    RECRUITING

    Phoenix, Arizona, 85054, United States

  • Medical Oncology Hematology Consultants /ID# 268560

    RECRUITING

    Newark, Delaware, 19713, United States

  • Memorial Sloan Kettering Cancer Center-Koch Center /ID# 251167

    RECRUITING

    New York, New York, 10065-6007, United States

  • Mt Sinai /ID# 251166

    RECRUITING

    New York, New York, 10029-6542, United States

  • NHO Revive Research Institute, LLC /ID# 267869

    RECRUITING

    Lincoln, Nebraska, 68506, United States

  • Northwest Medical Specialties Tacoma /ID# 267117

    RECRUITING

    Tacoma, Washington, 98405, United States

  • Odense University Hospital /ID# 251261

    RECRUITING

    Odense, Region Syddanmark, 5000, Denmark

  • Oncology Consultants /ID# 268323

    RECRUITING

    Houston, Texas, 77030, United States

  • Ottawa Hospital Research Institute /ID# 252151

    RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

  • Rabin Medical Center. /ID# 251330

    RECRUITING

    Petah Tikva, 4941492, Israel

  • Rocky Mountain Cancer Centers - Aurora /ID# 268574

    RECRUITING

    Aurora, Colorado, 80012, United States

  • Tel Aviv Sourasky Medical Center /ID# 251573

    RECRUITING

    Tel Aviv, Tel Aviv, 6423906, Israel

  • Texas Oncology - Central/South Texas /ID# 268563

    RECRUITING

    Austin, Texas, 78705, United States

  • Texas Oncology - Northeast Texas /ID# 268877

    RECRUITING

    Tyler, Texas, 75702, United States

  • The Chaim Sheba Medical Center /ID# 251329

    RECRUITING

    Ramat Gan, Tel Aviv, 5265601, Israel

  • The Christie Hospital /ID# 251774

    RECRUITING

    Manchester, M20 4BX, United Kingdom

    Contact Phone: •••-•••-••••

  • Tulane University School of Medicine /ID# 251204

    RECRUITING

    New Orleans, Louisiana, 70112, United States

  • University College London Hospital /ID# 251357

    RECRUITING

    London, Greater London, NW1 2BU, United Kingdom

  • University Of Cincinnati Medical Center /ID# 251746

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • University of North Carolina /ID# 251203

    RECRUITING

    Chapel Hill, North Carolina, 27514, United States

  • Vanderbilt Ingram Cancer Center /ID# 252470

    RECRUITING

    Nashville, Tennessee, 37232-0021, United States

  • Vejle Sygehus /ID# 251260

    RECRUITING

    Vejle, Region Syddanmark, 7100, Denmark

  • Virginia Cancer Specialists - Fairfax /ID# 268559

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Willamette Valley Cancer Institute and Research Center /ID# 267088

    RECRUITING

    Eugene, Oregon, 97401, United States

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA